# BPC-157 TB-500 FAQ: Safety, Mechanism, Dosing, and Regulatory Questions

> BPC-157 TB-500 FAQ — direct, cited answers on what the Wolverine blend is, how it works, the tumor-signal safety concern, long-term use, dosing context, and the FDA and WADA regulatory status.

Direct answers, logged to source. Safety, mechanism, dosing context, and the regulatory record for the two-peptide Wolverine blend.

## What the blend is

The definitional questions, answered from the chemistry and the literature.

## How it works and what the evidence shows

The mechanism and evidence questions.

## Safety and the tumor-signal concern

The safety questions are answered as documented considerations, not as demonstrated human outcomes.

## Dosing context and regulatory status

The dosing and regulatory questions. Dosing answers are research-handling context, never human guidance.

---

A two-lane dispatch manifest on the BPC-157 and TB-500 record — every constituent finding logged to its study, every blend-level claim cleared as no-human-data, with no clinic behind the console and nothing here routed for sale.